pharma · Opioid Use Disorder · Opioid Dependence
Indivior Pty
Indivior Pty Ltd
Indivior is a pharma organization headquartered in Richmond, USA. Primary therapeutic focus areas include Opioid Use Disorder, Opioid Dependence, Schizophrenia, Opioid Dependency, Opiate Dependence. NovaPharmaNews links
., Richmond, VA, US HQ
967 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- ., Richmond, VA, US
- Employees
- 967
- Programs
- 39
- Drugs
- 19
- Patents
- 34
Intranasal challenge drug
Phase 3 · small molecule · Heroin Dependence
Intranasal challenge drug for Heroin Dependence is a Phase 3 program (small_molecule) at Indivior Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code #5879
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Indivior Pty Ltd
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Heroin Dependence
- Status
- completed
- Trials
- 1